Search Results

[Efficacy of lobaplatin plus S-1 and the predictive value of circulating tumor cell in patients with advanced gastric cancer].

• Authors : Feng Q; Department of Gastroenterology, Liaocheng People's Hospital, Liaocheng 252000, China.; Zhao JR

Subjects: Neoplastic Cells, Circulating*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Cyclobutanes/Cyclobutanes/Cyclobutanes/*administration & dosage

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2018 Sep 23; Vol. 40 (9), pp. 696-702.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

影响Ⅲ 期食管癌术后患者预后的因素.

• Authors : 杨琼; 王玉祥; 何明

• Source: Chinese Journal of Oncology; 7/23/2016, Vol. 38 Issue 7, p530-537, 8p

Record details

[Clinical study on chemotherapy of lobaplatin combined with docetaxel in patients with relapsed ovarian cancer].

• Authors : Li X; Th ird Division of Department of Gynecological Oncology, Affi liated Cancer Hospital, Xiangya School of Medicine, Central South University, Changsha 410006, China .; Li Y

Subjects: Antineoplastic Combined Chemotherapy Protocols*; Cyclobutanes/Cyclobutanes/Cyclobutanes/*therapeutic use ; Neoplasms, Glandular and Epithelial/Neoplasms, Glandular and Epithelial/Neoplasms, Glandular and Epithelial/*drug therapy

• Source: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences [Zhong Nan Da Xue Xue Bao Yi Xue Ban] 2014 Nov; Vol. 39 (11), pp. 1131-6.Publisher:

Record details

[A safety analysis in patients treated with oxaliplatin plus S-1 as adjuvant therapy for gastric cancer].

• Authors : Zhou Y; Department of Medical Oncology, Chinese Academy of Medical Sciences, Beijing, China.; Huang J

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Organoplatinum Compounds/Organoplatinum Compounds/Organoplatinum Compounds/*administration & dosage

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2012 Nov; Vol. 34 (11), pp. 860-4.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

[Efficacy of docetaxel and nedaplatin combined with concurrent intensity modulated radiation therapy in the treatment of esophageal cancer].

• Authors : Bi LW; ; Zhang LZ

Subjects: Carcinoma, Squamous Cell*/Carcinoma, Squamous Cell*/Carcinoma, Squamous Cell*/drug therapy ; Carcinoma, Squamous Cell*/Carcinoma, Squamous Cell*/Carcinoma, Squamous Cell*/radiotherapy ; Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/drug therapy

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2012 Sep; Vol. 34 (9), pp. 710-1.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

[Pemetrexed alone versus pemetrexed combined with oxaliplatin as salvage therapy in stage IV lung adenocarcinoma].

• Authors : Liu Y; Department of Pulmonary, Chest Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200030, China.; Jiang Y

Subjects: Antineoplastic Combined Chemotherapy Protocols*; Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*pathology

• Source: Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2011 Sep; Vol. 14 (9), pp. 704-9.Publisher: Zhongguo fei ai za zhi bian ji wei yuan hui Country of Publication: China NLM ID: 101126433 Publication Model: Print Cited Medium: Internet

Record details

[Comparison between the effects of irinotecan or oxaliplatin combined with capecitabine in the treatment of advanced gastric cancer].

• Authors : Zhao WY; Department of Medical Oncology, Yijishan Hospital, Wannan Medical College, Anhui Wuhu 241000, China. ; Chen DY

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Camptothecin/Camptothecin/Camptothecin/*analogs & derivatives

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2011 Apr; Vol. 33 (4), pp. 295-8.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

[Efficacy and toxicity of FOLFOX6 regimen in treating colorectal cancer patients with liver metastasis].

• Authors : Wang GQ; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.; Wan DS

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Colonic Neoplasms/Colonic Neoplasms/Colonic Neoplasms/*drug therapy ; Fluorouracil/Fluorouracil/Fluorouracil/*administration & dosage

• Source: Ai zheng = Aizheng = Chinese journal of cancer [Ai Zheng] 2007 Apr; Vol. 26 (4), pp. 411-4.Publisher: Zhongshan da xue zhong liu fang zhi zhong xin Country of Publication: China NLM ID: 9424852 Publication Model: Print Cited Medium: Print

Record details

[Comparison of the therapeutic effects of pleural perfusion of NDP and cDDP in NSCLC patients with malignant pleural effusion].

• Authors : Cong YY; Medical Department of Breast Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin 150040, China.; Liu MY

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*complications ; Cisplatin/Cisplatin/Cisplatin/*administration & dosage

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2010 Jun; Vol. 32 (6), pp. 467-9.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

[Short-term effects of chemotherapy combined with hydroxycamptothecine and oxaliplatin in treatment of recurrent and metastatic colorectal cancer].

• Authors : Yao Y; Department of Medical Oncology, The Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, 200233, P. R. China. ; Sun YJ

Subjects: Antineoplastic Agents, Phytogenic/Antineoplastic Agents, Phytogenic/Antineoplastic Agents, Phytogenic/*administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Camptothecin/Camptothecin/Camptothecin/*analogs & derivatives

• Source: Ai zheng = Aizheng = Chinese journal of cancer [Ai Zheng] 2006 Aug; Vol. 25 (8), pp. 1035-8.Publisher: Zhongshan da xue zhong liu fang zhi zhong xin Country of Publication: China NLM ID: 9424852 Publication Model: Print Cited Medium: Print

Record details